CINXE.COM

<!DOCTYPE html><html data-wf-domain="www.shinefusion.com" data-wf-page="65a83006b74c01ae8837ec3c" data-wf-site="63bc8628e53c0011f41ce702" data-wf-collection="65a83006b74c01ae8837eb90" data-wf-item-slug="science-behind-lu-177-therapy-targeted-cancer-treatment"><head><meta charset="utf-8"/><title>SHINE Technologies | The Science Behind n.c.a. Lu-177 Therapy: A Breakthrough in Targeted Cancer Treatment</title><meta content="Explore how n.c.a. lutetium-177-based therapy precisely targets and treats cancer using radioactive properties. Learn about its unique ability to destroy cancer cells while minimizing damage to healthy tissue." name="description"/><meta content="SHINE Technologies | The Science Behind n.c.a. Lu-177 Therapy: A Breakthrough in Targeted Cancer Treatment" property="og:title"/><meta content="Explore how n.c.a. lutetium-177-based therapy precisely targets and treats cancer using radioactive properties. Learn about its unique ability to destroy cancer cells while minimizing damage to healthy tissue." property="og:description"/><meta content="https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177.png" property="og:image"/><meta content="SHINE Technologies | The Science Behind n.c.a. Lu-177 Therapy: A Breakthrough in Targeted Cancer Treatment" property="twitter:title"/><meta content="Explore how n.c.a. lutetium-177-based therapy precisely targets and treats cancer using radioactive properties. Learn about its unique ability to destroy cancer cells while minimizing damage to healthy tissue." property="twitter:description"/><meta content="https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177.png" property="twitter:image"/><meta property="og:type" content="website"/><meta content="summary_large_image" name="twitter:card"/><meta content="width=device-width, initial-scale=1" name="viewport"/><link href="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/css/shine-technologies.9c87be12a.css" rel="stylesheet" type="text/css"/><link href="https://fonts.googleapis.com" rel="preconnect"/><link href="https://fonts.gstatic.com" rel="preconnect" crossorigin="anonymous"/><script src="https://ajax.googleapis.com/ajax/libs/webfont/1.6.26/webfont.js" type="text/javascript"></script><script type="text/javascript">WebFont.load({ google: { families: ["Lato:100,100italic,300,300italic,400,400italic,700,700italic,900,900italic"] }});</script><script type="text/javascript">!function(o,c){var n=c.documentElement,t=" w-mod-";n.className+=t+"js",("ontouchstart"in o||o.DocumentTouch&&c instanceof DocumentTouch)&&(n.className+=t+"touch")}(window,document);</script><link href="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c704893421896a8a8058d7_ST%20Favicons-01.png" rel="shortcut icon" type="image/x-icon"/><link href="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c7048d05992419005fa37a_ST%20Favicons-02.png" rel="apple-touch-icon"/><script src="https://cdn.jsdelivr.net/gh/bigdatacloudapi/js-reverse-geocode-client@latest/bigdatacloud_reverse_geocode.min.js" type="text/javascript"></script>  <script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start': new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0], j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src= 'https://www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f); })(window,document,'script','dataLayer','GTM-PPP6M5V');</script>  <script type="text/javascript" src="https://cdn.weglot.com/weglot.min.js"></script> <script> Weglot.initialize({ api_key: 'wg_bbb03beeda9531c33a37c1dfe329eede5' }); </script> <style> .div-block-52 { z-index:5; } .wg-default.weglot-container--left, .wg-default.weglot-container--left .country-selector { right: 20px !important; left: auto !important; } </style> <script type="text/javascript" src="https://app.termly.io/embed.min.js" data-auto-block="off" data-website-uuid="00cdd85c-a387-4f34-bd1e-f46144fc33b6" defer ></script></head><body class="body-19"><div data-animation="default" data-collapse="medium" data-duration="400" data-easing="ease" data-easing2="ease" role="banner" class="mobile-navbar lightnav w-nav"><div class="container mobile"><a href="/" class="brand w-nav-brand"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/641c7f88f70044635a6e1024_SHINE%20Logo%202023.svg" loading="lazy" alt="SHINE logo in blue" class="image-15"/></a><nav role="navigation" class="nav-menu-2 w-nav-menu"><div data-hover="false" data-delay="0" class="dropdown-3 mobile w-dropdown"><div class="dropdown-toggle w-dropdown-toggle"><div data-w-id="efe49dfc-06c5-9cdd-fe84-6ea062828337" class="nav-link-2 link-block-2 link-block-3 link-block-4 link-block-5 link-block-6 link-block-7 link-block-8 link-block-9 link-block-10 link-block-11 mobile"><div class="div-block-79"><div class="text-block-15 darkmode">phases</div><div class="icon-4 w-icon-dropdown-toggle"></div></div><div class="div-block-40"></div></div></div><nav class="dropdown-list w-dropdown-list"><a href="/phase-1" class="nav-link-2 dropdown _1 mobile-tab w-inline-block"><div><div class="text-block-62">INSPECTING INDUSTRIAL COMPONENTS</div><div class="div-block-40 phase-1"></div></div></a><a data-w-id="efe49dfc-06c5-9cdd-fe84-6ea062828343" href="/phase-2" class="nav-link-2 dropdown-2 mobile-tab w-inline-block"><div><div>PRODUCING Medical isotopes</div><div class="div-block-40 phase-2"></div></div></a><a data-w-id="efe49dfc-06c5-9cdd-fe84-6ea062828348" href="/phase-3" class="nav-link-2 dropdown _3 mobiletab w-inline-block"><div><div>RECYCLING nuclear waste </div><div class="div-block-40 phase-3"></div></div></a><a data-w-id="efe49dfc-06c5-9cdd-fe84-6ea06282834d" href="/phase-4" class="nav-link-2 dropdown mobiletab w-inline-block"><div><div>GENERATING fusion energy</div><div class="div-block-40 phase-4"></div></div></a></nav></div><a data-w-id="efe49dfc-06c5-9cdd-fe84-6ea062828352" href="/why-fusion" class="nav-link-2 mobile w-inline-block"><div class="div-block-78"><div>why fusion?</div><div class="div-block-40"></div></div></a><div data-hover="false" data-delay="0" class="dropdown-3 mobile w-dropdown"><div class="dropdown-toggle w-dropdown-toggle"><div class="nav-link-2 link-block-2 link-block-3 link-block-4 link-block-5 link-block-6 link-block-7 link-block-8 link-block-9 link-block-10 link-block-11 mobile"><div class="div-block-79"><div class="text-block-15 darkmode">about</div><div class="icon-4 w-icon-dropdown-toggle"></div></div><div class="div-block-40"></div></div></div><nav class="dropdown-list w-dropdown-list"><a href="/about/company" class="nav-link-2 dropdown _1 mobile-tab careers w-inline-block"><div><div class="text-block-61">company</div><div class="div-block-40 phase-1"></div></div></a><a href="/about/meet-the-team" class="nav-link-2 dropdown _1 mobile-tab careers w-inline-block"><div><div class="text-block-61">meet the team</div><div class="div-block-40 phase-1"></div></div></a><a href="/insights-updates/all-categories" class="nav-link-2 dropdown-2 mobile-tab w-inline-block"><div><div>insights and updates</div><div class="div-block-40 phase-2"></div></div></a><a href="/about/sustainability" class="nav-link-2 dropdown _3 mobiletab w-inline-block"><div><div>sustainability </div><div class="div-block-40 phase-3"></div></div></a><a href="/about/careers" class="nav-link-2 dropdown mobiletab careers w-inline-block"><div><div>careers</div><div class="div-block-40 phase-4"></div></div></a></nav></div><a data-w-id="efe49dfc-06c5-9cdd-fe84-6ea062828379" href="/contact" class="nav-link-2 mobile w-inline-block"><div class="div-block-78"><div>contact</div><div class="div-block-40"></div></div></a><a href="/flare" class="shine-europe-link-block w-inline-block"><div class="image-container darkmode mobile"></div><div class="text-block-6 shine-europe">flare sales</div></a><a href="/isotope-sales" class="shine-europe-link-block w-inline-block"><div class="image-container darkmode mobile"></div><div class="text-block-6 shine-europe">isotope sales</div></a><div class="search-form-wrapper-2"><div tabindex="0" data-w-id="efe49dfc-06c5-9cdd-fe84-6ea062828383" class="open-icon"><div class="html-embed-8 w-embed"><svg xmlns="http://www.w3.org/2000/svg" xmlns:xlink="http://www.w3.org/1999/xlink" version="1.1" id="Capa_1" x="0px" y="0px" width="15px" height="100%" viewBox="0 0 475.084 475.084" style="enable-background:new 0 0 475.084 475.084;" xml:space="preserve"> <g> <path fill="CurrentColor" d="M464.524,412.846l-97.929-97.925c23.6-34.068,35.406-72.047,35.406-113.917c0-27.218-5.284-53.249-15.852-78.087 c-10.561-24.842-24.838-46.254-42.825-64.241c-17.987-17.987-39.396-32.264-64.233-42.826 C254.246,5.285,228.217,0.003,200.999,0.003c-27.216,0-53.247,5.282-78.085,15.847C98.072,26.412,76.66,40.689,58.673,58.676 c-17.989,17.987-32.264,39.403-42.827,64.241C5.282,147.758,0,173.786,0,201.004c0,27.216,5.282,53.238,15.846,78.083 c10.562,24.838,24.838,46.247,42.827,64.234c17.987,17.993,39.403,32.264,64.241,42.832c24.841,10.563,50.869,15.844,78.085,15.844 c41.879,0,79.852-11.807,113.922-35.405l97.929,97.641c6.852,7.231,15.406,10.849,25.693,10.849 c9.897,0,18.467-3.617,25.694-10.849c7.23-7.23,10.848-15.796,10.848-25.693C475.088,428.458,471.567,419.889,464.524,412.846z M291.363,291.358c-25.029,25.033-55.148,37.549-90.364,37.549c-35.21,0-65.329-12.519-90.36-37.549 c-25.031-25.029-37.546-55.144-37.546-90.36c0-35.21,12.518-65.334,37.546-90.36c25.026-25.032,55.15-37.546,90.36-37.546 c35.212,0,65.331,12.519,90.364,37.546c25.033,25.026,37.548,55.15,37.548,90.36C328.911,236.214,316.392,266.329,291.363,291.358z " fill="#333333"/> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> <g> </g> </svg></div></div><form action="/search" class="search-form w-form"><input class="search-input-3 w-input" maxlength="256" name="query" aria-label="Enter Search" placeholder="Search…" type="search" id="search" required=""/><input type="submit" aria-label="Search Button" class="search-button-2 w-button" value=""/></form><div tabindex="0" data-w-id="efe49dfc-06c5-9cdd-fe84-6ea062828388" class="close-icon"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/6424ff4171f3389d91d14e69_63fff70bcfe1c9891c92b1ea_Black%20Close%20X.svg" alt="A white X" class="x-icon"/></div></div></nav><div class="menu-button-2 w-nav-button"><div class="icon-3 w-icon-nav-menu"></div></div></div></div><div data-animation="default" data-collapse="medium" data-duration="400" data-easing="ease" data-easing2="ease" data-doc-height="1" role="banner" class="navbar light w-nav"><div class="search-wrapper light"><form action="/search" class="search-form-wrapper light w-form"><input class="search-input light w-input" maxlength="256" name="query" placeholder="Search…" type="search" id="search" required=""/><input type="submit" class="search-button w-button" value="Search"/></form></div><div class="container nav"><a href="/" class="brand w-nav-brand"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/641c7f88f70044635a6e1024_SHINE%20Logo%202023.svg" loading="lazy" alt="SHINE logo in blue" class="image"/></a><div class="container-3 w-container"><nav role="navigation" class="nav-menu w-clearfix w-nav-menu"><div data-hover="true" data-delay="0" class="dropdown-3 w-dropdown"><div class="dropdown-toggle w-dropdown-toggle"><a data-w-id="35739d4d-db03-66e0-267b-21a95d95baa0" href="/phases" class="nav-link-2 link-block-2 link-block-3 link-block-4 link-block-5 link-block-6 link-block-7 link-block-8 link-block-9 link-block-10 link-block-11 w-inline-block"><div class="text-block-15 darkmode light">phases</div><div class="div-block-40 darkmode"></div></a></div><nav class="dropdown-list w-dropdown-list"><a data-w-id="35739d4d-db03-66e0-267b-21a95d95baa5" href="/phase-1" class="nav-link-2 dropdown _1 w-inline-block"><div><div>INSPECTING INDUSTRIAL COMPONENTS</div><div class="div-block-40 phase-1"></div></div></a><a data-w-id="35739d4d-db03-66e0-267b-21a95d95baaa" href="/phase-2" class="nav-link-2 dropdown-2 w-inline-block"><div><div>PRODUCING Medical isotopes</div><div class="div-block-40 phase-2"></div></div></a><a data-w-id="35739d4d-db03-66e0-267b-21a95d95baaf" href="/phase-3" class="nav-link-2 dropdown _3 w-inline-block"><div><div>RECYCLING nuclear waste </div><div class="div-block-40 phase-3"></div></div></a><a data-w-id="35739d4d-db03-66e0-267b-21a95d95bab4" href="/phase-4" class="nav-link-2 dropdown w-inline-block"><div><div>GENERATING fusion power</div><div class="div-block-40 phase-4"></div></div></a></nav></div><div class="div-block-18"><div class="text-block-3 dashes light">//</div></div><a data-w-id="35739d4d-db03-66e0-267b-21a95d95babc" href="/why-fusion" class="nav-link-2 w-inline-block"><div class="text-block-41 light">why fusion?</div><div class="div-block-40 darkmode"></div></a><div class="div-block-18"><div class="text-block-3 dashes light">//</div></div><div data-hover="true" data-delay="0" class="dropdown-3 w-dropdown"><div data-w-id="35739d4d-db03-66e0-267b-21a95d95bac4" class="dropdown-toggle w-dropdown-toggle"><a href="/about/company" class="nav-link-2 link-block-2 link-block-3 link-block-4 link-block-5 link-block-6 link-block-7 link-block-8 link-block-9 link-block-10 link-block-11 w-inline-block"><div class="text-block-15 darkmode light">About</div><div class="div-block-40 darkmode"></div></a></div><nav class="dropdown-list about w-dropdown-list"><a data-w-id="c4b0d2a6-0e3a-13ec-64ec-fc856ca6a1cd" href="/about/meet-the-team" class="nav-link-2 dropdown-2 w-inline-block"><div><div>Meet the team</div><div data-w-id="c4b0d2a6-0e3a-13ec-64ec-fc856ca6a1d1" class="div-block-40"></div></div></a><a data-w-id="35739d4d-db03-66e0-267b-21a95d95bacf" href="/insights-updates/all-categories" class="nav-link-2 dropdown-2 w-inline-block"><div><div>Insights & Updates</div><div data-w-id="35739d4d-db03-66e0-267b-21a95d95bad3" class="div-block-40"></div></div></a><a data-w-id="35739d4d-db03-66e0-267b-21a95d95bad4" href="/about/sustainability" class="nav-link-2 dropdown-2 w-inline-block"><div><div>sustainability</div><div data-w-id="35739d4d-db03-66e0-267b-21a95d95bad8" class="div-block-40"></div></div></a><a data-w-id="35739d4d-db03-66e0-267b-21a95d95bad9" href="/about/careers" class="nav-link-2 dropdown-2 w-inline-block"><div><div>careers</div><div class="div-block-40"></div></div></a></nav></div><div class="div-block-18"><div class="text-block-3 dashes light">//</div><div data-hover="true" data-delay="0" class="dropdown-3 w-dropdown"><div class="dropdown-toggle w-dropdown-toggle"><a href="/about/company" class="nav-link-2 link-block-2 link-block-3 link-block-4 link-block-5 link-block-6 link-block-7 link-block-8 link-block-9 link-block-10 link-block-11 w-inline-block"><div class="text-block-15">Product & Services</div><div class="div-block-40"></div></a></div><nav class="dropdown-list about products w-dropdown-list"><a data-w-id="37a8bd0a-279f-cb1a-798d-9cccad7656b2" href="/isotope-sales" class="nav-link-2 dropdown-2 w-inline-block"><div><div>Ilumira - Isotope Sales</div><div class="div-block-40 phase-2"></div></div></a><a data-w-id="37a8bd0a-279f-cb1a-798d-9cccad7656b7" href="/flare" class="nav-link-2 dropdown-2 w-inline-block"><div><div>FLARE - RADIation effects testing sales</div><div class="div-block-40 phase-1"></div></div></a></nav></div></div><div class="div-block-18"><div class="text-block-3 dashes light">//</div></div><a data-w-id="35739d4d-db03-66e0-267b-21a95d95bae1" href="/contact" class="nav-link-2 w-inline-block"><div class="text-block-40 light">contact</div><div class="div-block-40 darkmode"></div></a><div class="div-block-18"><div class="text-block-3 dashes light">//</div></div><div class="nav-content-lef"><div class="search-icon-div"><a data-w-id="35739d4d-db03-66e0-267b-21a95d95baea" href="#" class="search-button-wrapper w-inline-block"><div class="search-form-button"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63f58690a43cb90f6a2f6fdc_5eccc3eadf7e1d555b420e09_search.svg" width="18" alt="A black magnifying glass" class="nav06_search_icon"/></div></a></div></div><div class="div-block-189"><a href="/isotope-sales" class="ilumira-link-block w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/665f622c366e4919e54c2f0f_Ilumira_logo_color.png" loading="lazy" sizes="(max-width: 991px) 100vw, (max-width: 1439px) 4vw, (max-width: 1919px) 5vw, 4vw" srcset="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/665f622c366e4919e54c2f0f_Ilumira_logo_color-p-500.png 500w, https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/665f622c366e4919e54c2f0f_Ilumira_logo_color-p-800.png 800w, https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/665f622c366e4919e54c2f0f_Ilumira_logo_color-p-1080.png 1080w, https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/665f622c366e4919e54c2f0f_Ilumira_logo_color.png 1500w" alt="" class="ilumira-nav"/></a><a href="/flare" class="flare-link-block w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/66e8312ce81264efbc6b52b6_SHINE_FLARE-logo_yellow_CMYK%20copy.svg" loading="lazy" alt="" class="flare-nav"/></a></div></nav><div class="menu-button w-nav-button"><div class="icon w-icon-nav-menu"></div></div></div></div></div><div class="heading-background"><img src="https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177.png" loading="lazy" alt="" sizes="100vw" srcset="https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177-p-500.png 500w, https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177-p-800.png 800w, https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177-p-1080.png 1080w, https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177-p-1600.png 1600w, https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177-p-2000.png 2000w, https://cdn.prod.website-files.com/63ea6cdb6682ff600e6305a1/6737b2237f4d48ec64651c94_The%20Science%20Behind%20Lu-177.png 2067w" class="image-17"/><div class="blog-image-overlay"></div><div class="insights-updates-header blog"><div class="container"><div class="heading-space"><div class="div-block-80"><h1 style="opacity:0" class="heading-9 blog"> The Science Behind n.c.a. Lu-177 Therapy: A Breakthrough in Targeted Cancer Treatment</h1></div><div><div class="logos-headline"><div class="subtitle small white w-dyn-bind-empty"></div><div class="horizontal-line-2 white"></div></div></div></div></div></div></div><div class="section no-top-padding"><div class="container"><div class="wrapper"><div class="project-description-wrapper"><div id="w-node-_9613111e-7ffc-df92-5430-a9293a8fabc5-8837ec3c" class="project-description top-grey-border"><div class="blog-title"> The Science Behind n.c.a. Lu-177 Therapy: A Breakthrough in Targeted Cancer Treatment</div><div class="event-container w-condition-invisible"><div class="event-list-wrapper w-dyn-list"><div class="w-dyn-empty"><div>No items found.</div></div></div></div><div id="w-node-a7a5bcf7-9f9c-d161-f288-77299405ecfa-8837ec3c" class="rich-text-2 w-richtext"><p>As one of the fastest-growing markets in oncology, <a href="https://www.shinefusion.com/blog/shine-technologies-and-nucleus-radiopharma-partner-to-advance-radioligand-cancer-treatments">Lutetium-177-based radioligand therapy (RLT)</a> is transforming treatment options for patients worldwide. </p><p>Lutetium-177 (Lu-177) is a radioactive isotope of lutetium, a rare earth metal, with a half-life of about 6.7 days. Unlike diagnostic isotopes such as <a href="/molybdenum-99">molybdenum-99 </a>used in SPECT imaging, Lu-177's unique radioactive properties make it a powerful tool for directly treating certain cancers. </p><h2>Why is lutetium-177 used in cancer therapy? </h2><p><a href="https://www.shinefusion.com/blog/what-is-n-c-a-lutetium-177-lu-177">Lu-177</a> has become a cornerstone of modern cancer treatment due to several key characteristics that make it particularly effective: </p><ul role="list"><li>Its 6.7-day half-life provides enough time for preparation, shipping, and treatment while maintaining therapeutic effectiveness </li></ul><ul role="list"><li>When paired with cancer-seeking molecules, it can precisely target and treat tumors throughout the body </li></ul><ul role="list"><li>Its radiation properties allow for both treatment and imaging, enabling doctors to track the therapy's effectiveness overtime </li></ul><ul role="list"><li>It can treat both large tumors and small metastases </li></ul><ul role="list"><li>The targeted nature of Lu-177 therapy helps minimize damage to healthy tissue </li></ul><p>For patients with advanced-stage cancers, particularly those who have exhausted other treatment options, Lu-177-based therapies have shown remarkable results in extending survival rates and improving quality of life. </p><h2>How does Lu-177 work? </h2><p>Lu-177 is a beta emitter, meaning it releases high-energy electrons as it decays. This beta radiation is particularly valuable for cancer treatment because it has a limited range in body tissues – only traveling a few millimeters – which helps contain its effects to the targeted treatment area. When precisely targeted, the beta radiation can destroy cancer cell DNA while minimizing damage to surrounding healthy tissue. Lu-177 also emits gamma radiation, which enables doctors to track the treatment's distribution in the body. </p><p>The combination of these properties – targeted cell destruction and trackability – makes Lu-177 especially effective for treating metastatic cancers where tumors have spread throughout the body. </p><h2>Understanding carrier-added vs. non-carrier-added Lu-177 </h2><p>There are two methods for producing Lu-177, resulting in different forms of the isotope: </p><p><strong>Carrier-added Lu-177 (c.a. Lu-177)</strong> is produced through the "direct" method by irradiating naturally occurring Lu-176 with neutrons. While conceptually simpler, this process creates both Lu-177 and an unwanted isotope, Lu-177m. </p><p>The c.a. process: </p><ul role="list"><li>Makes the purification of Lu-177 difficult, resulting in lower therapeutic concentrations of Lu-177 </li></ul><ul role="list"><li>Creates more radioactive waste requiring special handling and disposal </li></ul><ul role="list"><li>Reduces the overall effectiveness of the final drug formulation </li></ul><ul role="list"><li>Results in longer-lived radioactive contamination due to Lu-177m </li></ul><p><strong>Non-carrier-added Lu-177</strong> (<strong>n.c.a. Lu-77</strong>, like <a href="/videos/introducing-ilumira">Ilumira</a>) is produced through an "indirect" method that, while more complex, yields superior results. This process involves: </p><ol start="1" role="list"><li>Starting with highly enriched ytterbium-176 (Yb-176)</li></ol><ol start="2" role="list"><li>Bombarding it with neutrons to produce Yb-177 </li></ol><ol start="3" role="list"><li>Allowing Yb-177 to decay into Lu-177 through beta particle emission </li></ol><ol start="4" role="list"><li>Separating the pure Lu-177 from the target material </li></ol><p>The n.c.a. process results in: </p><ul role="list"><li>Pure Lu-177 with minimal Lu-177m contamination </li></ul><ul role="list"><li>Higher Lu-177 specific activity for better therapeutic effectiveness </li></ul><ul role="list"><li>Less radioactive waste </li></ul><ul role="list"><li>More efficient and environmentally friendly production </li></ul><ul role="list"><li>Better suitability for therapeutic applications </li></ul><p>The quality of the starting materials and sophistication of the separation process directly impact the final product's purity and effectiveness. This is particularly important for therapeutic applications where higher specific activity translates to better treatment outcomes. </p><h2>Current medical applications </h2><p><a href="https://www.shinefusion.com/blog/shine-technologies-partners-with-blue-earth-therapeutics-for-first-supply-of-ilumira-from-its-new-facility">N.c.a. Lu-177</a> has proven particularly effective in treating: </p><ul role="list"><li>Advanced prostate cancer through prostate-specific membrane antigen (PSMA) therapy, targeting PSMA, a protein found in elevated levels around prostate tumors </li></ul><ul role="list"><li>Neuroendocrine tumors through peptide receptor radionuclide therapy (PRRT), where Lu-177 is combined with cell-targeting proteins similar to natural hormones </li></ul><ul role="list"><li>Other cancers through ongoing clinical trials </li></ul><p>A typical treatment course involves three to four sessions. For patients with advanced-stage cancer where other treatments have failed, Lu-177 therapy has shown remarkable results in increasing survival rates and improving quality of life. </p><h2>Production and quality requirements </h2><p>Manufacturing<a href="https://www.shinefusion.com/isotope-sales"> medical-grade n.c.a. Lu-177</a> requires sophisticated nuclear technology and expertise. The production process must meet applicable <a href="https://www.shinefusion.com/blog/shine-technologies-llc-announces-submission-of-fda-drug-master-file-for-non-carrier-added-lutetium-177">FDA regulatory requirements</a> and quality standards for medical use. Advanced production methods, like those used to create Ilumira, can achieve exceptional purity levels that enable optimal performance in therapeutic applications. </p><p>Like other medical radioisotopes, Lu-177's relatively short half-life means it cannot be stockpiled and must be continuously produced to meet researchers’ and patient needs. This makes <a href="https://www.shinefusion.com/videos/shine-opening-largest-lutetium-production-facility-in-north-america">reliable, ongoing production capabilities</a> crucial for ensuring consistent patient access to treatment. </p><h2>Delivery methods and treatment process </h2><p>In prostate-specific membrane antigen (PSMA) therapy for prostate cancer, the isotope is paired with a molecule that specifically seeks out and binds to PSMA proteins, which exist in highly elevated levels around prostate tumors. This targeting mechanism ensures the radiation is delivered precisely where needed. Similarly, in peptide receptor radionuclide therapy (PRRT) for neuroendocrine tumors, Lu-177 is bonded with specific proteins to create radiopeptides that target tumor cells throughout the body. </p><p>As a theranostic treatment, one of<a href="https://www.shinefusion.com/blog/lutetium-177-information-sheet"> Lu-177's unique advantages </a>is its dual capability to both track and treat disease. When paired with targeting molecules, Lu-177 can help doctors identify cancer locations and then deliver treatment to those exact spots. This combined diagnostic and therapeutic (“theranostic”) approach enables more precise treatment planning and monitoring. </p><p>A typical treatment course involves three to four sessions. The process includes: </p><ul role="list"><li>Initial diagnostic dose to determine how much of the drug will be absorbed by tumors versus healthy tissue </li></ul><ul role="list"><li>Treatment planning and dose optimization based on diagnostic imaging </li></ul><ul role="list"><li>Careful preparation of therapeutic doses based on patient-specific factors </li></ul><ul role="list"><li>Intravenous administration of the radiopharmaceutical </li></ul><ul role="list"><li>Post-treatment imaging to confirm proper distribution </li></ul><ul role="list"><li>Monitoring through follow-up scans and assessments </li></ul><p>The results can be remarkable. Treatment can effectively reduce tumor size and prevent further spread, with some patients showing dramatic improvements in clinical markers. </p><h2>Quality considerations in n.c.a. Lu-177 </h2><p>The effectiveness of Lu-177-based treatments depends significantly on the quality of the isotope used. <a href="https://www.shinefusion.com/lutetium-177">Higher purity n.c.a. Lu-177</a> enables more efficient labeling with targeting molecules and can result in better treatment outcomes. Ilumira, for example, consistently achieves exceptional purity levels that exceed European Pharmacopeia standards, leading to superior labeling efficiency in therapeutic applications. </p><h2>Innovations in Lu-177 production </h2><p>A key factor in n.c.a. Lu-177 quality is the production of the starting material, ytterbium-176. SHINE has developed proprietary technology for producing highly pure Yb-176, which streamlines the manufacturing process and ensures consistent quality. At our facility in Fitchburg, Wisconsin, we employ<a href="http://www.phoenixneutronimaging.com"> uniquely scalable and efficient nuclear separation techniques</a> that make the production process both sustainable and cost-effective. </p><h2>The future of cancer treatment with Lu-177 </h2><p>N.c.a. lu-177's precision and effectiveness make it increasingly vital in modern cancer therapy. Its ability to target specific cancer cells while sparing healthy tissue represents a significant advancement in treatment options, particularly for patients with advanced or treatment-resistant cancers. </p><p>As research continues and new applications emerge, reliable access to high-quality n.c.a. Lu-177 becomes increasingly critical for researchers, and healthcare providers and their patients. With advanced production facilities like <a href="/cassi-grand-opening">Cassiopeia</a> now operating in Janesville, WI, the medical community has access to domestically-produced n.c.a. Lu-177 that consistently meets the highest standards of quality and performance. </p></div><div class="rich-text-2 w-dyn-bind-empty w-richtext"></div><a href="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/66d8661fc4b333e4df0bc7a1_Lutetium-177%20Information%20Sheet-EU%20Distribution.pdf" class="submit-button-2 w-condition-invisible w-button">Lutetium-177 Information Sheet (EU Distribution)</a><a href="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/6660cd2337e19cc871e66e57_Ilumira%20Brochure_v2.pdf" class="submit-button-2 w-condition-invisible w-button">Ilumira Information Sheet</a><a href="#" class="submit-button-2 blog w-condition-invisible w-button">download PDF RESOURCE HERE</a></div><div id="w-node-_9613111e-7ffc-df92-5430-a9293a8fabd3-8837ec3c" class="project-features dark"><div class="sticky-services-menu"><div class="div-block-82"><div class="div-block-84"><h3>Share This Story, Choose<br/>Your Platform!</h3><h3 class="w-condition-invisible">Share These Events,<br/>Choose Your Platform!</h3></div><div class="w-layout-grid grid-9"><div id="w-node-_5e55d1e8-590e-c4fa-1d0d-38a861057db0-8837ec3c" class="w-embed"> <a href="https://www.facebook.com/sharer/sharer.php?u=https://www.shinefusion.com/blog/science-behind-lu-177-therapy-targeted-cancer-treatment" class="div-block-83 w-inline-block" title="Facebook" target="_blank" onclick="window.open('https://www.facebook.com/sharer/sharer.php?u=' + encodeURIComponent(document.URL) + '&t=' + encodeURIComponent(document.URL),'','width=600,height=800'); return false;"> <img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63bc8ea1330e721e7c56518b_facebook%20icon.png" loading="lazy" alt="A facebook Icon" class="facebook" /> </a></div><div id="w-node-a6b8af5c-855b-ce75-b053-4d4550fb0f17-8837ec3c" class="w-embed"> <a href="https://twitter.com/intent/tweet?url=https://www.shinefusion.com/blog/science-behind-lu-177-therapy-targeted-cancer-treatment" class="div-block-83 w-inline-block" target="_blank" title="Share on Twitter" onclick="window.open('https://twitter.com/intent/tweet?text=' + encodeURIComponent(document.title) + ':%20 ' + encodeURIComponent(document.URL),'','width=600,height=800'); return false;"> <img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/66f5548361cbc75626e5cfa5_x-logo-twitter-new-brand-512.png" loading="lazy" alt="" class="twitter"></a></div><div id="w-node-_782b2948-331f-3e88-66d1-2b89716a90ab-8837ec3c" class="w-embed"> <a href="https://www.linkedin.com/shareArticle?mini=true&url=https://www.shinefusion.com/blog/science-behind-lu-177-therapy-targeted-cancer-treatment" class="div-block-83 w-inline-block" target="_blank" title="LinkedIn" onclick="window.open('http://www.linkedin.com/shareArticle?mini=true&url=' + encodeURIComponent(document.URL) + '&title=' + encodeURIComponent(document.title),'','width=600,height=800'); return false;"> <img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63bc8ea12a98b6b2a053113f_Linkedin%20Icon.png" loading="lazy" alt="Linkedin Icon" class="linkedin"></a></div><div id="w-node-dfa21619-05e5-5799-0c63-8e7e4a8fffc1-8837ec3c" class="w-embed"><a href="https://www.youtube.com/@shinetechnologies/videos" target="_blank" class="div-block-83 w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/66f554b56b4e101b34be560d_youtube-app-white-icon.webp" loading="lazy" alt="" class="youtube"></a></div></div></div><div id="w-node-_9613111e-7ffc-df92-5430-a9293a8fabe6-8837ec3c" class="list-heading-wrapper"><div class="subtitle">Related Content</div></div><div><div class="w-dyn-list"><div role="list" class="service-menu-list w-dyn-items"><div role="listitem" class="w-dyn-item"><a href="/blog/hope-delivered-shines-lu-177-supply-chain-solution-offers-new-hope-for-cancer-patients" class="menu-list-item small dark w-inline-block"><div id="w-node-_76d47744-0bc6-1476-0c76-3db0fbce6edb-8837ec3c" class="div-block-157"><div class="subtitle-name-grid"><div class="list-item-text subtitle white blog">Hope Delivered: SHINE's Lu-177 Supply Chain Solution Offers New Hope for Cancer Patients </div></div></div><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark.png" loading="lazy" id="w-node-bed4de1b-aff0-ba54-7f5b-0ff3ccca9cae-8837ec3c" sizes="(max-width: 767px) 14px, (max-width: 991px) 2vw, (max-width: 1279px) 18px, 1vw" alt="A black arrow pointing to the right." srcset="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark-p-500.png 500w, https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark.png 570w" class="list-item-arrow"/></a></div><div role="listitem" class="w-dyn-item"><a href="/blog/shine-ceo-chrysalis-to-be-worlds-largest-medical-isotope-producer" class="menu-list-item small dark w-inline-block"><div id="w-node-_76d47744-0bc6-1476-0c76-3db0fbce6edb-8837ec3c" class="div-block-157"><div class="subtitle-name-grid"><div class="list-item-text subtitle white blog">SHINE CEO: Chrysalis to be World’s Largest Medical Isotope Producer</div></div></div><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark.png" loading="lazy" id="w-node-bed4de1b-aff0-ba54-7f5b-0ff3ccca9cae-8837ec3c" sizes="(max-width: 767px) 14px, (max-width: 991px) 2vw, (max-width: 1279px) 18px, 1vw" alt="A black arrow pointing to the right." srcset="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark-p-500.png 500w, https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark.png 570w" class="list-item-arrow"/></a></div><div role="listitem" class="w-dyn-item"><a href="/blog/glytherix-to-partner-with-shine-technologies-for-advancing-targeted-radiotherapy-in-aggressive-cancers" class="menu-list-item small dark w-inline-block"><div id="w-node-_76d47744-0bc6-1476-0c76-3db0fbce6edb-8837ec3c" class="div-block-157"><div class="subtitle-name-grid"><div class="list-item-text subtitle white blog">GlyTherix to Partner with SHINE Technologies for Advancing Targeted Radiotherapy in Aggressive Cancers</div></div></div><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark.png" loading="lazy" id="w-node-bed4de1b-aff0-ba54-7f5b-0ff3ccca9cae-8837ec3c" sizes="(max-width: 767px) 14px, (max-width: 991px) 2vw, (max-width: 1279px) 18px, 1vw" alt="A black arrow pointing to the right." srcset="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark-p-500.png 500w, https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63c70035e76078777dd562c0_arrow-right_dark.png 570w" class="list-item-arrow"/></a></div></div></div></div></div></div></div></div></div></div><div class="footer"><div class="container footer"><div class="div-block"><div class="footer-logo-wrapper"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/641c7f88f70044635a6e1024_SHINE%20Logo%202023.svg" loading="lazy" alt="SHINE logo in blue" class="image-2"/></div><div class="footer-text-wrapper"><div class="text-block">3400 Innovation Ct.<br/>Janesville, WI 53546</div></div><div class="social-icons-wrapper"><div class="w-layout-grid grid"><a href="https://www.facebook.com/SHINEfusion" target="_blank" class="div-block-2 w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63bc8ea1330e721e7c56518b_facebook%20icon.png" loading="lazy" alt="A facebook Icon" class="facebook"/></a><a href="https://www.instagram.com/shinefusion/" target="_blank" class="div-block-2 w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63bc8ea15d2cfac5328c0e8d_Instagram%20Icon.png" loading="lazy" alt="An Instagram Icon" class="facebook"/></a><a href="https://twitter.com/shinefusion" target="_blank" class="div-block-2 w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/64ed03a10fb216ac641b73bb_logo.svg" loading="lazy" alt="Twitter Logo" class="facebook"/></a><a href="https://www.linkedin.com/company/shinefusion/" target="_blank" class="div-block-2 w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63bc8ea12a98b6b2a053113f_Linkedin%20Icon.png" loading="lazy" alt="Linkedin Icon" class="facebook"/></a><a href="https://www.youtube.com/channel/UCHb5yev7Yg71Vc_iFGkFkyA" target="_blank" class="div-block-2 w-inline-block"><img src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/63bc8ea1588335f9666b8830_Youtube%20Icon.png" loading="lazy" alt="Youtube Icon" class="facebook"/></a></div></div><div class="div-block-3"><div class="text-block-2">FOLLOW OUR journey</div><div class="text-block-52">Sign Up for Our Newsletter</div></div><div class="div-block-4"><div class="w-embed w-script"><style> #hsForm_0538d66b-1761-4176-8069-380d387d613b { display: flex; flex-wrap: wrap; gap: 8px; } #hsForm_0538d66b-1761-4176-8069-380d387d613b label { color: #fff; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs_email { width: calc(65% - 8px); } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs_submit { width: 35%; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs_recaptcha { width: 100%; order: 3; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .input input { color: var(--white); background-color: rgba(255, 255, 255, .24); border-radius: 0; margin-bottom: 0; margin-right: 10px; border: 1px solid #ccc; padding: 8px 12px; width: 220px; height: 38px; padding: 0; margin: 0; width: 100%; padding: 9px 15px; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs-email label { display:none; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs-submit input { border: 0px solid var(--white); background-image: linear-gradient(to right, var(--phase-2-dark), var(--shine-medium-blue) 50%, var(--shine-light-blue)); color: var(--white); letter-spacing: 3px; text-transform: uppercase; margin-top: 0; font-size: 12px; font-weight: 600; transition: all .3s; height: 38px; padding: 9px 15px; cursor:pointer; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .input, #hsForm_0538d66b-1761-4176-8069-380d387d613b .input:hover { background-color: transparent; padding:0px; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .input input::placeholder { color:#ffffff; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs-error-msgs { display:none; } @media screen and (max-width:768px) { #hsForm_0538d66b-1761-4176-8069-380d387d613b { justify-content: center; align-items: center; gap: 5px; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs_email, #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs_submit { width: 100%; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .input { padding:0px; max-width:220px; margin: 0 auto; } #hsForm_0538d66b-1761-4176-8069-380d387d613b .hs-submit .actions { text-align: center; } } </style> <script charset="utf-8" type="text/javascript" src="//js.hsforms.net/forms/embed/v2.js"></script> <script> hbspt.forms.create({ region: "na1", portalId: "6087894", formId: "0538d66b-1761-4176-8069-380d387d613b" }); </script></div><div class="form-block-6 w-form"><form id="wf-form-Newsletter-Sign-up-Form" name="wf-form-Newsletter-Sign-up-Form" data-name="Newsletter Sign-up Form" method="get" class="form-2 form-3 form-6 form-7 form-8 footer" data-wf-page-id="65a83006b74c01ae8837ec3c" data-wf-element-id="8296314e-232f-fcfa-b3de-06bc6697f71e"><input class="text-field-2 text-field-3 text-field-10 w-input" maxlength="256" name="email" data-name="Email" placeholder="Email Address" type="email" id="email" required=""/><input type="submit" data-wait="Please wait..." class="submit-button-2 footer w-button" value="Submit"/></form><div class="success-message-4 w-form-done"><div>Thank you! Your submission has been received!</div></div><div class="w-form-fail"><div><strong>Oops!</strong> Something went wrong while submitting the form.</div></div></div></div><div class="div-block-5"><a href="/about/founders-letter" class="div-block-6 w-inline-block"><div class="text-block-3">Founder's Letter</div></a><div class="div-block-11"><div class="text-block-3 dashes">//</div></div><a href="/current-investors" class="div-block-8 w-inline-block"><div class="text-block-3">current Investors</div></a><div class="div-block-12"><div class="text-block-3 dashes">//</div></div><a href="/compliance-helpline" class="div-block-7 w-inline-block"><div class="text-block-3">compliance helpline</div></a><div class="div-block-13"><div class="text-block-3 dashes">//</div></div><a href="/privacy-policy" class="div-block-9 w-inline-block"><div class="text-block-3">privacy policy</div></a><div class="div-block-14"><div class="text-block-3 dashes">//</div></div><a href="/terms-and-conditions" class="div-block-10 w-inline-block"><div class="text-block-3">terms & conditions</div></a></div></div></div><div class="div-block-75"><div class="text-block-23">© SHINE Technologies, LLC | All Rights Reserved</div></div></div><script src="https://d3e54v103j8qbb.cloudfront.net/js/jquery-3.5.1.min.dc5e7f18c8.js?site=63bc8628e53c0011f41ce702" type="text/javascript" integrity="sha256-9/aliU8dGd2tb6OSsuzixeV4y/faTqgFtohetphbbj0=" crossorigin="anonymous"></script><script src="https://cdn.prod.website-files.com/63bc8628e53c0011f41ce702/js/shine-technologies.70d284fa0.js" type="text/javascript"></script> <noscript><iframe src="https://www.googletagmanager.com/ns.html?id=GTM-PPP6M5V" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript>  <script type="text/javascript"> var result; var jsonResponse; if (document.getElementById("json-result") != null) { result = document.getElementById("json-result"); } const Http = new XMLHttpRequest(); function getLocation() { console.log("getLocation Called"); var bdcApi = "https://api.bigdatacloud.net/data/reverse-geocode-client" navigator.geolocation.getCurrentPosition( (position) => { bdcApi = bdcApi + "?latitude=" + position.coords.latitude + "&longitude=" + position.coords.longitude + "&localityLanguage=en"; getApi(bdcApi); }, (err) => { getApi(bdcApi); }, { enableHighAccuracy: true, timeout: 5000, maximumAge: 0 }); } function getApi(bdcApi) { Http.open("GET", bdcApi); Http.send(); Http.onreadystatechange = function () { if (this.readyState == 4 && this.status == 200) { var data = this.responseText; jsonResponse = JSON.parse(data); if (result != null) { result.innerHTML = jsonResponse["continent"]; } } }; } getLocation(); </script> </body></html>